Maze Therapeutics, Inc. (MAZE) Current Reports & Earnings Releases
Upcoming
- 2026-11-05 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-17 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-08-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-10 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-22 | 8-K | Officer / Director Changes | SEC |
| 2026-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-22 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-25 | 8-K | Results of Operations, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-04 | 8-K | Material Agreement, Termination of Agreement, Direct Financial Obligation | SEC |
| 2025-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-06 | 8-K | Officer / Director Changes | SEC |
| 2025-09-11 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-09-02 | 8-K | Officer / Director Changes | SEC |
| 2025-08-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-31 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.